Futility monitoring for randomized clinical trials with non-proportional hazards: An optimal conditional power approach

被引:1
|
作者
Wang, Xiaofei [1 ]
George, Stephen L. [1 ]
机构
[1] Duke Univ, Sch Med, Dept Biostat & Bioinformat, 2424 Erwin Rd,Suite 1102, Durham, NC 27705 USA
关键词
Average hazard ratio; clinical trial design; delayed treatment effect; futility rules; non-proportional hazards; SAMPLE-SIZE; SURVIVAL; DESIGN; TESTS;
D O I
10.1177/17407745231181908
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Standard futility analyses designed for a proportional hazards setting may have serious drawbacks when non-proportional hazards are present. One important type of non-proportional hazards occurs when the treatment effect is delayed. That is, there is little or no early treatment effect but a substantial later effect. Methods We define optimality criteria for futility analyses in this setting and propose simple search procedures for deriving such rules in practice. Results We demonstrate the advantages of the optimal rules over commonly used rules in reducing the average number of events, the average sample size, or the average study duration under the null hypothesis with minimal power loss under the alternative hypothesis. Conclusion Optimal futility rules can be derived for a non-proportional hazards setting that control the loss of power under the alternative hypothesis while maximizing the gain in early stopping under the null hypothesis.
引用
收藏
页码:603 / 612
页数:10
相关论文
共 45 条
  • [31] The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt
    Royston, Patrick
    Parmar, Mahesh K. B.
    STATISTICS IN MEDICINE, 2011, 30 (19) : 2409 - 2421
  • [32] Estimating Conditional Power for Sequential Monitoring of Covariate Adaptive Randomized Designs: The Fractional Brownian Motion Approach
    Yang, Yiping
    Zhu, Hongjian
    Lai, Dejian
    FRACTAL AND FRACTIONAL, 2021, 5 (03)
  • [33] Correcting for non-compliance of repeated binary outcomes in randomized clinical trials: Randomized analysis approach
    Matsuyama, Yutaka
    Lui, Kung-Jong
    STATISTICS IN MEDICINE, 2007, 26 (25) : 4679 - 4683
  • [34] Correcting for non-compliance of repeated binary outcomes in randomized clinical trials: randomized analysis approach
    Matsuyama, Y
    STATISTICS IN MEDICINE, 2002, 21 (05) : 675 - 687
  • [35] Sequential Monitoring of Covariate-Adaptive Randomized Clinical Trials With Non-Parametric Approaches
    Chen, Xiaotian
    Yu, Jun
    Zhu, Hongjian
    Wang, Li
    STATISTICS IN MEDICINE, 2025, 44 (06)
  • [36] Estimating Covariate-Adjusted Log Hazard Ratios in Randomized Clinical Trials Using Cox Proportional Hazards Models and Nonparametric Randomization Based Analysis of Covariance
    Saville, Benjamin R.
    Koch, Gary G.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (02) : 477 - 490
  • [37] A non-parametric approach to predict the recruitment for randomized clinical trials: an example in elderly inpatient settings
    Alejandro, Villasante-Tezanos
    Kuo, Yong-Fang
    Christopher, Kurinec
    Yisheng, Li
    Yu, Xiaoying
    BMC MEDICAL RESEARCH METHODOLOGY, 2024, 24 (01)
  • [38] Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit
    Catrin Tudur Smith
    Paula Williamson
    Ashley Jones
    Alan Smyth
    Simon Langton Hewer
    Carrol Gamble
    Trials, 15
  • [39] Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit
    Smith, Catrin Tudur
    Williamson, Paula
    Jones, Ashley
    Smyth, Alan
    Hewer, Simon Langton
    Gamble, Carrol
    TRIALS, 2014, 15
  • [40] Non-parametric covariance methods for incidence density analyses of time-to-event data from a randomized clinical trial and their complementary roles to proportional hazards regression
    Tangen, CM
    Koch, GG
    STATISTICS IN MEDICINE, 2000, 19 (08) : 1039 - 1058